Genome editing technologies and their potential to treat neurologic disease.

作者: Nicolas N. Madigan , Nathan P. Staff , Anthony J. Windebank , Eduardo E. Benarroch

DOI: 10.1212/WNL.0000000000004558

关键词:

摘要: Genome editing refers to a process of making precise and permanent changes in the genetic code cells, tissues, whole organisms. The first step this is program an enzyme called nuclease bind DNA sequence, whereby will cut DNA. This double-stranded break turn induce cell make repair at that site, which change sequence. mechanism can be utilized either knock out or introduce selected genes. Given how rapidly gene systems are influencing diverse applications biomedical research, biotechnology, agriculture,1 clinical neurology mutations causing disease, incorporate genes might therapeutic benefit, on near horizon. following cases illustrate such approach may used develop new ex vivo (case 1) 2) therapies for neurologic respectively, highlight some translational challenges using these molecular reagents safely ethically patients.

参考文章(57)
Dino Terzic, Jacob R. Maxon, Leah Krevitt, Christina Dibartolomeo, Tarini Goyal, Walter C. Low, James R. Dutton, Ann M. Parr, Directed Differentiation of Oligodendrocyte Progenitor Cells From Mouse Induced Pluripotent Stem Cells. Cell Transplantation. ,vol. 25, pp. 411- 424 ,(2016) , 10.3727/096368915X688137
Benjamin P. Kleinstiver, Michelle S. Prew, Shengdar Q. Tsai, Ved V. Topkar, Nhu T. Nguyen, Zongli Zheng, Andrew P. W. Gonzales, Zhuyun Li, Randall T. Peterson, Jing-Ruey Joanna Yeh, Martin J. Aryee, J. Keith Joung, Engineered CRISPR-CAS9 nucleases with altered PAM specificity Nature. ,vol. 523, pp. 481- 485 ,(2016) , 10.1038/NATURE14592
Han Xu, Tengfei Xiao, Chen-Hao Chen, Wei Li, Clifford A Meyer, Qiu Wu, Di Wu, Le Cong, Feng Zhang, Jun S Liu, Myles Brown, X Shirley Liu, None, Sequence determinants of improved CRISPR sgRNA design Genome Research. ,vol. 25, pp. 1147- 1157 ,(2015) , 10.1101/GR.191452.115
Samuel H. Sternberg, Sy Redding, Martin Jinek, Eric C. Greene, Jennifer A. Doudna, DNA interrogation by the CRISPR RNA-guided endonuclease Cas9 Nature. ,vol. 507, pp. 62- 67 ,(2014) , 10.1038/NATURE13011
Carolin Anders, Ole Niewoehner, Alessia Duerst, Martin Jinek, Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease Nature. ,vol. 513, pp. 569- 573 ,(2014) , 10.1038/NATURE13579
Chen Yu, Yanxia Liu, Tianhua Ma, Kai Liu, Shaohua Xu, Yu Zhang, Honglei Liu, Marie La Russa, Min Xie, Sheng Ding, Lei S. Qi, Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells Cell Stem Cell. ,vol. 16, pp. 142- 147 ,(2015) , 10.1016/J.STEM.2015.01.003
Takeshi Maruyama, Stephanie K Dougan, Matthias C Truttmann, Angelina M Bilate, Jessica R Ingram, Hidde L Ploegh, Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining Nature Biotechnology. ,vol. 33, pp. 538- 542 ,(2015) , 10.1038/NBT.3190
Federico Mingozzi, Katherine A. High, Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges Nature Reviews Genetics. ,vol. 12, pp. 341- 355 ,(2011) , 10.1038/NRG2988
Ming-San Ma, Erik Boddeke, Sjef Copray, Pluripotent Stem Cells for Schwann Cell Engineering Stem Cell Reviews and Reports. ,vol. 11, pp. 205- 218 ,(2015) , 10.1007/S12015-014-9577-1
Wolfgang Singer, Phillip A. Low, Optimizing clinical trial design for multiple system atrophy: lessons from the rifampicin study. Clinical Autonomic Research. ,vol. 25, pp. 47- 52 ,(2015) , 10.1007/S10286-015-0281-2